Next Steps For AI, Machine Learning In Biopharma

A common thread emerging among new biopharma companies; they're hiring as many data scientists as wet lab scientists and their data server budgets are growing faster than that of their protein purification process. Here's what that means to you and your company. Bill Gates isn't the only tech industry insider turned life sciences "outsider" currently throwing his weight around the biosciences. There's a new breed of biopharma leader on the rise, an ilk identified not by their lab coats but by their pocket protectors, and not by their hair nets but by their propeller heads. The market worth of data scientists and digital transformation specialists is rapidly appreciating as biopharma firms seek to explore how harnessing data and appropriately processing it will help them work faster and smarter, from drug discovery to clinical trials and beyond.